Robert M. Centor, MD; Brad Spellberg, MD
Disclosures: Dr. Centor has disclosed the following: Honoraria: Medscape. Dr. Spellberg has disclosed the following: Stock options/holdings: BioAIM, ExBaq, MycoMed, Motif. Consultantship: Alexion, Paratek, Acurx, Merck, Klaris, Shionogi.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Catharine B. Stack, PhD, MS, Deputy Editor, Statistics, reports that she has stock holdings in Pfizer, Johnson & Johnson, and Colgate-Palmolive. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.
Audio. Annals On Call - Shorter-Duration Antibiotics for Community-Acquired Pneumonia: Dr. Centor discusses the duration of antibiotic therapy for patients with pneumonia with Dr. Brad Spellberg of the University of Southern California Medical Center.
Other Audio Options: Download MP3
Centor RM, Spellberg B. Annals On Call - Shorter-Duration Antibiotics for Community-Acquired Pneumonia. Ann Intern Med. 2019;171:OC1. doi: https://doi.org/10.7326/A19-0017
Download citation file:
Published: Ann Intern Med. 2019;171(9):OC1.
Infectious Disease, Pneumonia, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use